Does Ariad's Leukemia Drug Have Hidden Potential?

With its launch of chronic myeloid leukemia drug Iclusig, Ariad Pharmaceuticals just topped Wall Street estimates for the quarter and is showing significant promise despite what on the surface appear to be meager numbers.

In this video, health-care analyst David Williamson discusses its potential to continue to surprise investors and beat Wall Street going forward. Watch and find out if Ariad is a stock investors need on their radars.

What could be a slam-dunk for investors is a company working to eradicate the macro trend Warren Buffett called "the tapeworm that's eating at American competitiveness." Find out what Buffett was referring to in our free report: "What's Really Eating at America's Competitiveness." Just click here for free, immediate access.

Follow David on Twitter: @MotleyDavid.


Read/Post Comments (2) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On May 07, 2013, at 8:04 PM, Cado05 wrote:

    Who compares first q. to market value? Do you know any professional market maker who does this? You're such unprofessional person.

  • Report this Comment On May 07, 2013, at 8:26 PM, Cado05 wrote:

    Many companies don't have any revenue , so for example in your logic where is Clovis Oncology Inc? Trading around $860M Market cap????

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2415542, ~/Articles/ArticleHandler.aspx, 10/21/2014 6:20:04 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement